Resources

Sonara Health has been recognized as one of America’s Greatest Startup Workplaces 2026, celebrating the company’s commitment to building a mission-driven, collaborative, and people-first culture.

In-person callbacks can create unnecessary stress and logistical challenges for patients in recovery, often acting as another barrier to treatment retention. Incorporating virtual callbacks into a diversion control plan can ease patient burden while still supporting key goals.

Using funds from a state opioid settlement, Sonara Health is now partnering with MedMark Treatment Centers Washington to make its remote dosing platform available to Pennsylvania patients.

Discover how a hybrid care model can improve access to opioid treatment by reducing barriers, minimizing risks with take-home methadone, and enhancing patient engagement.

For many OUD patients, the daily travel to an OTP clinic isn’t just an inconvenience—it’s a major barrier to treatment retention and recovery. By implementing a hybrid care model with take-home flexibility, OTPs can reduce these burdens while maintaining patient safety and engagement.

A new community-based study explores the realities of accessing opioid agonist treatment (OAT) in rural and remote communities, highlighting barriers related to travel, stigma, and treatment flexibility.

Discover Sonara’s 2024 Year in Review: expanding take-home methadone access, advancing OUD research, and driving equitable care through advocacy and innovation.

With the final rule on "Medications for the Treatment of Opioid Use Disorder" now in effect, OTP’s must decide on the best steps to implement these guidelines.

Learn how debunking methadone myths can improve Opioid Use Disorder (OUD) treatment outcomes. Explore how Sonara’s remote dosing solution empowers take-home methadone programs, enhances accessibility, and supports personalized recovery journeys.

Sonara® is collaborating with the University of Arkansas for Medical Sciences to responsibly broaden access to take-home methadone for patients who qualify.

For friends and families of individuals with Opioid Use Disorder, understanding the challenges that the holidays present is essential to providing support. In this article, we’ll examine the resources and strategies that may be most effective in supporting individuals with OUD over the holidays.

Sonara Health® has received a $2.5M grant from the National Institute on Drug Abuse (NIDA) to fund the second phase of a study on Remote Observed Methadone Evaluation (ROME).

In this article, we’ll examine the different ways OTPs benefit their communities at large, along with some key improvements that will help OTPs increase their impact in the future.

With more than $50 billion in legal settlements earmarked for the opioid crisis, there's an enormous funding opportunity for OTPs looking to prevent overdose deaths and explore new treatment innovations.

People receiving methadone for opioid use disorder must often visit a clinic every day to ensure the drug isn’t diverted into the illicit market. Now some providers are experimenting with remote monitoring to reduce patients’ burden.

Learn how Sonara’s virtual dosing solution can help you satisfy the requirements of the new Innovation in Behavioral Health model from CMMI.

Under SAMHA’s new guidelines, it’s more important than ever for providers to make informed clinical decisions.

Learn about one patient’s journey toward gaining greater autonomy with Sonara’s Virtual Dosing Window™.